Patent ID: 7605181

Claim:
A method for treating a mammalian subject with a condition selected from the group consisting of insulin resistance syndrome, Type II diabetes, and hyperlipidemia, comprising administering to the subject an amount of a biologically active agent effective to treat the condition, wherein the agent is a compound of the formula: wherein n is 1 or 2; m is 1, 2, 4, or 5; q is 0 or 1; t is 0 or 1; R 2 is alkyl having from 1 to 3 carbon atoms; R 3 is hydrogen, halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3 carbon atoms; A is 2,6-dimethyiphenyl; and R 1 is hydrogen or alkyl having 1 or 2 carbon atoms; or when R 1 is hydrogen, a pharmaceutically acceptable salt of the compound.